Amsterdam Molecular Therapeutics Provides Status Update On Glybera(R)
AMSTERDAM, May 10, 2011 /PRNewswire/ -- Amsterdam Molecular Therapeutics , a leader in the field of human gene therapy, provided today a status update on Glybera (alipogene tiparvovec), its gene…